Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-21

Clinical Trial Update: Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether fluconazole affects ASCA antibody levels after Crohn's disease surgical resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)

Snippet

Sponsor: University Hospital, Lille | Conditions: Crohn's Disease Aggravated | Phase 2 | Status: COMPLETED